Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

Davis, Sally J.; Sheppard, Karen E.; Anglesio, Michael S.; George, Joshy; Traficante, Nadia; Fereday, Sian; Intermaggio, Maria P.; Menon, Usha; Gentry-Maharaj, Aleksandra; Lubinski, Jan; Gronwald, Jacek; Pearce, Celeste Leigh; Pike, Malcolm C.; Wu, Anna; Kommoss, Stefan; Pfisterer, Jacobus; du Bois, Andreas; Hilpert, Felix; Ramus, Susan J.; Bowtell, David D. L.; Huntsman, David G.; Pearson, Richard B.; Simpson, Kaylene J.; Campbell, Ian G.; Gorringe, Kylie L.

Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

Autor(en):

Davis, Sally J.; Sheppard, Karen E.; Anglesio, Michael S.; George, Joshy; Traficante, Nadia; Fereday, Sian; Intermaggio, Maria P.; Menon, Usha; Gentry-Maharaj, Aleksandra; Lubinski, Jan; Gronwald, Jacek; Pearce, Celeste Leigh; Pike, Malcolm C.; Wu, Anna; Kommoss, Stefan; Pfisterer, Jacobus; du Bois, Andreas; Hilpert, Felix; Ramus, Susan J.; Bowtell, David D. L.; Huntsman, David G.; Pearson, Richard B.; Simpson, Kaylene J.; Campbell, Ian G.; Gorringe, Kylie L.

Tübinger Autor(en):

Kommoss, Stefan

Erschienen in:

Molecular Cancer Therapeutics (2015), Bd. 14, H. 6, S. 1495-1503

Verlagsangabe:

Amer Assoc Cancer Research

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1158/1535-7163.MCT-15-0039

ISSN:

1535-7163